% 0期刊文章% Meredith Pescatello % Nimish Mohile %詹妮弗Serventi % Bethann塞耶斯%杰奎琳贝洱%一个飞碟双多向冠军和亚军,卷边%萨拉·哈迪% T结构早期先进优质的神经胶质瘤患者的护理计划的结果(S17.006) % D R 10.1212 / WNL 2023%。0000000000203293 % J首页神经病学% P V 100% N 17补充2% 3477% X目的:评估的影响将结构化早期高级保健计划(SEACP)集成到照顾患者恶性神经胶质瘤(毫克)。背景:SEACP利用率低下是在癌症和MG由于预后的关键,进行性认知障碍和病人自主权。设计/方法:供应商进行培训和使用检查清单进行SEACP访问,包括病人和照顾者。我们执行一个IRB-approved回顾性分析40 SEACP访问2年以上。我们回顾了文档的SEACP坚持临终质量度量和评估影响(EOLQM)和先进的保健计划(ACP)文档。卡方检验和t用于比较结果发表pre-SEACP队列从我们的机构。定性数据对于患者和提供者使用主题内容分析的经验进行了分析。结果:所有SEACP访问由先进实践提供者或注册护士。54%是tele-visits。讨论的主题包括:存在问题(85%)、ACP文档(81%),临床问题(77%),和病人价值(74%)。病人完成SEACP (n = 40)比患者更可能ACP记录pre-SEACP队列(85% vs . 44%;p < 0.05),已经完成了ACP文档本身而不是通过一个代理(81% vs . 55.0%;p < . 01)和更高的临终关怀招生> 7天前死亡(89%比70.0%; p<.05). Evaluation of qualitative data revealed that 100% of patients found SEACP to be helpful in decision making. 75% of caregivers agreed that “I understand my loved one’s illness better after this visit” and 100% of providers agreed SEACP “improved understanding of patient wishes.”Conclusions: Our findings suggest that SEACP is effectively performed by non-physician providers and by telemedicine. SEACP improved ACP documentation, patient involvement in ACP decisions and EOLQM while creating a forum to discuss end of life concerns. Patients, caregivers and providers all viewed SEACP positively.Disclosure: Mrs. Pescatello has nothing to disclose. Dr. Mohile has nothing to disclose. Ms. Serventi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novocure. Mrs. Sayers has nothing to disclose. Mrs. Behr has nothing to disclose. Dr. Hemminger has nothing to disclose. Dr. Hardy has received research support from Del Monte Institute for Neuroscience. %U

map